Burrows Scott L

Burrows Scott L is listed in filings as Chief Financial Officer at Spyre Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 13, 2026, including 1 public disclosure. Recent filings connect the profile to Spyre Therapeutics, Inc. (SYRE). The current snapshot covers public activity from Jan 13, 2026. Reported amounts are shown as $4.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.